why choose us

First received: August 31, 2023

Clinical Trial: Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Central Nervous System Lymphoma

Study Type: OBSERVATIONAL


Official Title: Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Brief Summary: This study evaluates pharmacogenomic effects on high-dose methotrexate clearance in patients with diffuse large B-cell lymphoma.

Read more